Back

Effects of immunosuppressive therapy on the clinical outcomes in patients with cardiac sarcoidosis

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and clinical care Cardiac Diseases EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Hans Ebbinghaus

Heart Center of Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail
Is there an association between device-detected atrial fibrillation and diabetes? A propensity score-matched analysis from the Italian Home Monitoring Expert Alliance project
Doctor G. Malanchini (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Prediction of atrial fibrillation in patients without heart failure: validation study in 3.3 million individuals
Doctor H. Ismail (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
A virtual atrial fibrillation clinic after pulmonary vein isolation: lessons learned from 1000 patient-years.
Doctor J. Balt (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Analysis of physical activity and sleep behaviour preceding malignant ventricular arrhythmias treated by implanted cardioverter-defibrillators
Mrs F. Raijmakers (Amsterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and clinical care

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Cardiac Sarcoidosis treated with non-steroidal immunosuppressive therapy
thumbnail
Congress Presentation
Long-term efficacy of tailored prolonged immunosuppressive therapy in biopsy-proven virus- negative myocarditis: a single center propensity weighted study
thumbnail
Congress Presentation
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources